You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Health

  • Study: Artificial Sweeteners may promote diabetes
    Using artificial sweeteners may set the stage for diabetes in some people by hampering the way their bodies handle sugar, suggests a preliminary study done mostly in mice.
  • Americans’ bellies expanding fast, CDC says
    The number of American men and women with big-bellied, apple-shaped figures – the most dangerous kind of obesity – has climbed at a startling rate over the past decade, according to a government study.
  • FDA mulls shock therapy
    Some cut themselves. Others slam their heads against walls or desks – so hard that one girl detached both retinas and a young man triggered a stroke. Another pulled out all his teeth.
Advertisement

Lab recalls generic Lipitor

Troubled Indian firm acts on worries of glass in drug

– Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.

Ranbaxy is a subsidiary of Ranbaxy Laboratories Ltd., India’s biggest drugmaker. The subsidiary is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple Ranbaxy factories over the past several years. The FDA also has alleged the company lied about test results for more than two dozen of its generic drugs several years ago.

On Friday, Ranbaxy posted a notice on its U.S. website, saying it’s recalling 10-, 20- and 40-milligram doses of tablets of atorvastatin calcium. That’s generic Lipitor, the cholesterol fighter that reigned for years as the world’s top-selling drug.

The recall includes 41 lots of the drug, nearly all with 90 pills per bottle, but three lots contain 500 pills per bottle. It’s unclear how many bottles are in each lot, but medicine batches typically contain many thousands of pills. The 80-milligram strength tablets are not affected.

Ranbaxy spokesman Chuck Caprariello did not answer questions or provide any additional information beyond the statement on the company’s website.

“Ranbaxy is proactively recalling the drug product lots out of an abundance of caution,” the website statement read. “This recall is being conducted with the full knowledge of the U.S. FDA.”

Patients who’ve filled a prescription can contact their pharmacy to determine whether it was made by Ranbaxy and whether it came from a recalled lot.

Advertisement